Canine brain tumours: a model for the human disease?

J Hicks, S Platt, M Kent, A Haley - Veterinary and comparative …, 2017 - Wiley Online Library
Canine brain tumours are becoming established as naturally occurring models of disease to
advance diagnostic and therapeutic understanding successfully. The size and structure of …

[HTML][HTML] Genetic/molecular alterations of meningiomas and the signaling pathways targeted

P Domingues, M González-Tablas, Á Otero… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Meningiomas are usually considered to be benign central nervous system tumors; however,
they show heterogenous clinical, histolopathological and cytogenetic features associated …

Recurrence/regrowth in grade I meningioma: how to predict?

GTC Carvalho, WC Silva-Martins… - Frontiers in …, 2020 - frontiersin.org
The HLA-G and HLA-E molecules, Ki67, progesterone (PR), estrogen (ER) and androgen
receptors (AR), p53, COX-2, and HER2 were studied to assess whether the biological …

The role of systemic inflammatory cells in meningiomas

J Haslund-Vinding, JR Møller, M Ziebell, F Vilhardt… - Neurosurgical …, 2022 - Springer
The aim of this review is to describe the inflammatory systemic cell infiltrate and its role in
pathophysiology and prognostic implications of meningiomas. Articles from PubMed …

Impact of shape irregularity in medial sphenoid wing meningiomas on postoperative cranial nerve functioning, proliferation, and progression-free survival

J Wach, J Naegeli, M Vychopen, C Seidel… - Cancers, 2023 - mdpi.com
Simple Summary The shape of meningiomas has been suggested as a potential indicator of
the WHO grade. Medial sphenoid wing meningiomas are surgically challenging skull base …

Systemic therapy for recurrent meningioma

E Le Rhun, S Taillibert… - Expert review of …, 2016 - Taylor & Francis
ABSTRACT Introduction: Meningioma comprise 20-30% of all primary brain tumors.
Notwithstanding surgery and radiotherapy, a subset of patients will manifest recurrent …

Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas

T Csonka, B Murnyák, R Szepesi, A Kurucz… - Folia …, 2014 - termedia.pl
Meningiomas are one of the most frequent intracranial tumours, with 13 histological types
and three grades according to the 2007 WHO Classification of Tumours of the Central …

Immunohistochemical characterization of procaspase-3 overexpression as a druggable target with PAC-1, a procaspase-3 activator, in canine and human brain …

LJ Schlein, B Fadl-Alla, HC Pondenis, S Lezmi… - Frontiers in …, 2019 - frontiersin.org
Gliomas and meningiomas are the most common brain neoplasms affecting both humans
and canines, and identifying druggable targets conserved across multiple brain cancer …

[HTML][HTML] Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma

Y Cui, Z Sun, X Li, C Leng, L Zhang… - Oncology …, 2016 - spandidos-publications.com
Abstract Cyclooxygenase‑2 (COX‑2) and interleukin‑32 (IL‑32) expression has been
examined in various carcinomas and inflammations, and has been suggested to be …

Association between nonsteroidal anti‐inflammatory drug use and brain tumour risk: a meta‐analysis

Y Liu, Y Lu, J Wang, L Xie, T Li, Y He… - British journal of …, 2014 - Wiley Online Library
Aims Several epidemiological studies have evaluated the association between nonsteroidal
anti‐inflammatory drugs (NSAID s) and brain tumour risk. However, results from these …